[NDRA] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
13-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -46.27%
YoY- -23.74%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 0 0 0 0 0 287 0 -
PBT -3,440 -2,658 -3,258 -3,414 -2,759 -909 -980 23.26%
Tax 23 -8 396 684 288 6 373 -37.13%
NP -3,463 -2,658 -3,258 -3,414 -2,759 -909 -980 23.40%
Tax Rate - - - - - - - -
Total Cost 3,463 2,658 3,258 3,414 2,759 1,196 980 23.40%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -316.69 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -1.10 -1.27 -2.73 -9.19 -14.05 -4.65 -5.02 -22.34%
EPS Diluted -1.10 -1.27 -2.73 -9.19 -14.05 -4.65 -5.02 -22.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.